326 - 350 of 446
Number of results to display per page
TitleCreatorRelation Is Part Of
326 Positional Testing in Acute Vestibular Syndrome: A Transversal and Longitudinal StudyJoao Lemos; Ana Martins; Cristina Duque; Sara Pimentel; Cesar Nunes; Antonio GoncalvesNANOS 2019: Scientific Platform II
327 Positional Testing in Acute Vestibular Syndrome: A Transversal and Longitudinal StudyJoao Lemos; Ana Martins; Cristina Duque; Sara Pimentel; Cesar Nunes; Antonio GoncalvesNANOS 2019: Scientific Platform II
328 Positional Testing in Acute Vestibular Syndrome: A Transversal and Longitudinal StudyJoao Lemos; Ana Martins; Cristina Duque; Sara Pimentel; Cesar Nunes; Antonio GoncalvesNANOS 2019: Scientific Platform II
329 The Post-Illumination Pupil Response (PIPR) Is Associated With Cognitive Measures in an Epidemiologic CohortYanjun Chen; AAron Pinto; Adam Paulsen; Carla Schubert; Laura Hancock; Barbara Klein; Ron Klein; Karen CruickshanksNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
330 Presentation of NAION in a Global Treatment TrialMark J. KupersmithNANOS Annual Meeting 2019: Scientific Platform Presentations (Session 1)
331 Presentation of NAION in a Global Treatment TrialMark Kupersmith; Neil Miller; Mays El-Dairi; Leonard Levin; Sharon KlierNANOS 2018: Scientific Platform I
332 Presentation of NAION in a Global Treatment TrialMark Kupersmith; Neil Miller; Mays El-Dairi; Leonard Levin; Sharon KlierNANOS 2018: Scientific Platform I
333 Prevalence and histopathological signatures of optic disc drusen based on microscopy of 1713 enucleated eyesMarie Skougaard; Steffen Heegaard; Lasse Malmqvist; Steffen HamannNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
334 Progressive Neurodegeneration of the Retinal Nerve Fiber Layer in Veterans with Mild Traumatic Brain InjuryRandy H. KardonNANOS Annual Meeting 2019: Scientific Platform Presentations (Session 1)
335 Progressive Neurodegeneration of the Retinal Nerve Fiber Layer in Veterans with Mild Traumatic Brain InjuryRandy H. Kardon; Kelvin Lim; Casey Gilmore; Jan Full; Mona Garvin; Jui-Kai Wang; Johannes LedolterNANOS 2018: Scientific Platform I
336 Progressive Neurodegeneration of the Retinal Nerve Fiber Layer in Veterans with Mild Traumatic Brain InjuryRandy H. Kardon; Kelvin Lim; Casey Gilmore; Johannes LedolterNANOS 2018: Scientific Platform I
337 Progressive Supranuclear Palsy Saccadic Deficits: Infraredoculographic Features and ChallengesJohn Martone; Todd Hudson; Weiwei Dai; John-Ross Rizzo; Steven Frucht; Laura Balcer; Steven Galetta; Janet RuckerNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
338 Prostate cancer and the visual systemSteven A. Newman, MDNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
339 Pseudo von Graefe's Sign following Operative Vaginal DeliverySwati Handa; Su Ann Lim; Fong Yee FooNAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology
340 Pseudo-Internuclear Ophthalmoplegia as the Presenting Sign of Giant Cell ArteritisBayan Al Othman; Ashwini Kini; Andrew Lee; Claudia Prospero Ponce; Garrett JensenNAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology
341 Quantification of Optic Nerve Head Venous Tortuosity in Idiopathic Intracranial Hypertension Using Optos ImagingSalina Teja; Vivek Patel; Kimberley Gokoffski; Mahnaz ShahidiNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
342 Quantitative Optical Coherence Tomography Angiography (OCTA) and Visual Field Defects in Idiopathic Intracranial HypertensionMelinda Y. ChangNANOS 2019: Scientific Platform II
343 Quantitative Optical Coherence Tomography Angiography (OCTA) and Visual Field Defects in Idiopathic Intracranial HypertensionMelinda Y. ChangNANOS 2019: Scientific Platform II
344 Quantitative Optical Coherence Tomography Angiography (OCTA) and Visual Field Defects in Idiopathic Intracranial HypertensionMelinda Y. ChangNANOS 2019: Scientific Platform II
345 rAAV2/2-ND4 Treatment of Leber Optic Neuropathy: 72-Week Data from the REVERSE Phase III Clinical TrialNancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal; Valerio Carelli; Patrick Yu-Wai-Man; Jose Sahel; Barrett KatzNANOS 2019: Scientific Platform III
346 rAAV2/2-ND4 Treatment of Leber Optic Neuropathy: 72-Week Data from the REVERSE Phase III Clinical TrialNancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal; Valerio Carelli; Patrick Yu-Wai-Man; Jose Sahel; Barrett KatzNANOS 2019: Scientific Platform III
347 rAAV2/2-ND4 Treatment of Leber Optic Neuropathy: 72-Week Data from the REVERSE Phase III Clinical TrialNancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal; Valerio Carelli; Patrick Yu-Wai-Man; Jose Sahel; Barrett KatzNANOS 2019: Scientific Platform III
348 Radiation Optic NeuropathyNorah S. Lincoff; Osman Farooq NANOS Annual Meeting 2019: Hot Topics: How Do I Treat?
349 Radiation Optic NeuropathyNorah S. Lincoff; Osman FarooqNANOS Annual Meeting 2019: Hot Topics: How Do I Treat?
350 Radiation Optic NeuropathyNorah S. LincoffNANOS Annual Meeting 2019: Hot Topics: How Do I Treat?
326 - 350 of 446